|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2003-3-7
|
|
pubmed:abstractText |
To test the efficacy of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy for the second-line treatment of Helicobacter pylori infection.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0269-2813
|
|
pubmed:author |
pubmed-author:ChanC KCK,
pubmed-author:FOXJ FJF,
pubmed-author:FRYJ FJF,
pubmed-author:FungF M YFM,
pubmed-author:HuW H CWH,
pubmed-author:LalK BKB,
pubmed-author:LamS KSK,
pubmed-author:WongB C YBC,
pubmed-author:WoodW AWA,
pubmed-author:XiaH H XHH,
pubmed-author:YuenM FMF
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
17
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
553-60
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12622764-2-Pyridinylmethylsulfinylbenzimidazoles,
pubmed-meshheading:12622764-Adult,
pubmed-meshheading:12622764-Aged,
pubmed-meshheading:12622764-Anti-Bacterial Agents,
pubmed-meshheading:12622764-Anti-Infective Agents,
pubmed-meshheading:12622764-Anti-Ulcer Agents,
pubmed-meshheading:12622764-Benzimidazoles,
pubmed-meshheading:12622764-Drug Resistance,
pubmed-meshheading:12622764-Drug Therapy, Combination,
pubmed-meshheading:12622764-Female,
pubmed-meshheading:12622764-Follow-Up Studies,
pubmed-meshheading:12622764-Helicobacter Infections,
pubmed-meshheading:12622764-Helicobacter pylori,
pubmed-meshheading:12622764-Humans,
pubmed-meshheading:12622764-Male,
pubmed-meshheading:12622764-Middle Aged,
pubmed-meshheading:12622764-Ofloxacin,
pubmed-meshheading:12622764-Omeprazole,
pubmed-meshheading:12622764-Rifabutin,
pubmed-meshheading:12622764-Treatment Outcome
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second-line treatment for Helicobacter pylori infection.
|
|
pubmed:affiliation |
Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong, China.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
